Free Trial

Enfusion (ENFN) News Today

Enfusion logo
$11.10 -0.01 (-0.05%)
As of 10:22 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Enfusion, Inc. stock logo
Fox Run Management L.L.C. Invests $265,000 in Enfusion, Inc. (NYSE:ENFN)
Fox Run Management L.L.C. bought a new stake in Enfusion, Inc. (NYSE:ENFN - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 25,736 shares of the company's stock, valued at approximately $265,000. Other institutional i
Enfusion, Inc. stock logo
Royce & Associates LP Increases Stock Position in Enfusion, Inc. (NYSE:ENFN)
Royce & Associates LP lifted its stake in Enfusion, Inc. (NYSE:ENFN - Free Report) by 84.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 184,078 shares of the company's stock after acquiring an additional 84,363 sh
Enfusion, Inc. stock logo
Enfusion, Inc. (NYSE:ENFN) General Counsel Sells $19,289.10 in Stock
Enfusion, Inc. (NYSE:ENFN - Get Free Report) General Counsel Matthew Campobasso sold 1,695 shares of Enfusion stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $11.38, for a total transaction of $19,289.10. Following the completion of the sale, the general counsel now owns 70,946 shares in the company, valued at approximately $807,365.48. This trade represents a 2.33 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Enfusion, Inc. stock logo
Enfusion, Inc. (NYSE:ENFN) Insider Bronwen Bastone Sells 3,126 Shares
Enfusion, Inc. (NYSE:ENFN - Get Free Report) insider Bronwen Bastone sold 3,126 shares of the business's stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $11.38, for a total transaction of $35,573.88. Following the sale, the insider now directly owns 221,875 shares in the company, valued at $2,524,937.50. The trade was a 1.39 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Enfusion, Inc. stock logo
Enfusion, Inc. (NYSE:ENFN) CFO Sells $52,860.10 in Stock
Enfusion, Inc. (NYSE:ENFN - Get Free Report) CFO Bradley Herring sold 4,645 shares of Enfusion stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $11.38, for a total value of $52,860.10. Following the completion of the sale, the chief financial officer now owns 324,689 shares of the company's stock, valued at $3,694,960.82. This trade represents a 1.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Enfusion, Inc. stock logo
Enfusion, Inc. (NYSE:ENFN) CEO Oleg Movchan Sells 11,452 Shares
Enfusion, Inc. (NYSE:ENFN - Get Free Report) CEO Oleg Movchan sold 11,452 shares of Enfusion stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $11.39, for a total transaction of $130,438.28. Following the transaction, the chief executive officer now owns 631,847 shares in the company, valued at approximately $7,196,737.33. This trade represents a 1.78 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.
Enfusion, Inc. stock logo
Neal Pawar Sells 14,560 Shares of Enfusion, Inc. (NYSE:ENFN) Stock
Enfusion, Inc. (NYSE:ENFN - Get Free Report) COO Neal Pawar sold 14,560 shares of the stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $11.38, for a total transaction of $165,692.80. Following the completion of the sale, the chief operating officer now directly owns 1,217,067 shares in the company, valued at approximately $13,850,222.46. The trade was a 1.18 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Enfusion, Inc. stock logo
Matthew Campobasso Sells 1,081 Shares of Enfusion, Inc. (NYSE:ENFN) Stock
Enfusion, Inc. (NYSE:ENFN - Get Free Report) General Counsel Matthew Campobasso sold 1,081 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $11.48, for a total value of $12,409.88. Following the completion of the sale, the general counsel now directly owns 72,641 shares in the company, valued at $833,918.68. This represents a 1.47 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Enfusion, Inc. stock logo
Bradley Herring Sells 1,533 Shares of Enfusion, Inc. (NYSE:ENFN) Stock
Enfusion, Inc. (NYSE:ENFN - Get Free Report) CFO Bradley Herring sold 1,533 shares of Enfusion stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $11.48, for a total transaction of $17,598.84. Following the completion of the transaction, the chief financial officer now owns 329,334 shares of the company's stock, valued at $3,780,754.32. This trade represents a 0.46 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
Enfusion, Inc. stock logo
Insider Selling: Enfusion, Inc. (NYSE:ENFN) Insider Sells 2,064 Shares of Stock
Enfusion, Inc. (NYSE:ENFN - Get Free Report) insider Bronwen Bastone sold 2,064 shares of the company's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $11.48, for a total transaction of $23,694.72. Following the completion of the transaction, the insider now directly owns 225,001 shares in the company, valued at approximately $2,583,011.48. The trade was a 0.91 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
Enfusion, Inc. stock logo
Neal Pawar Sells 2,769 Shares of Enfusion, Inc. (NYSE:ENFN) Stock
Enfusion, Inc. (NYSE:ENFN - Get Free Report) COO Neal Pawar sold 2,769 shares of the firm's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $11.48, for a total value of $31,788.12. Following the completion of the sale, the chief operating officer now directly owns 1,231,627 shares of the company's stock, valued at approximately $14,139,077.96. This trade represents a 0.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.
Enfusion, Inc. stock logo
Insider Selling: Enfusion, Inc. (NYSE:ENFN) CEO Sells 2,790 Shares of Stock
Enfusion, Inc. (NYSE:ENFN - Get Free Report) CEO Oleg Movchan sold 2,790 shares of the company's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $11.48, for a total transaction of $32,029.20. Following the completion of the sale, the chief executive officer now owns 643,299 shares of the company's stock, valued at $7,385,072.52. This represents a 0.43 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
Enfusion, Inc. stock logo
Enfusion (ENFN) to Release Earnings on Tuesday
Enfusion (NYSE:ENFN) will be releasing earnings before the market opens on Tuesday, March 11, Financial Modeling Prep reports.
Enfusion, Inc. stock logo
Enfusion (NYSE:ENFN) Announces Quarterly Earnings Results, Misses Expectations By $0.02 EPS
Enfusion (NYSE:ENFN - Get Free Report) issued its quarterly earnings data on Monday. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.03 by ($0.02). Enfusion had a return on equity of 6.67% and a net margin of 1.70%.
Enfusion, Inc. stock logo
Impax Asset Management Group plc Raises Position in Enfusion, Inc. (NYSE:ENFN)
Impax Asset Management Group plc increased its holdings in Enfusion, Inc. (NYSE:ENFN - Free Report) by 31.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 890,000 shares of the company's stock after pu
Enfusion, Inc. stock logo
Enfusion, Inc. (NYSE:ENFN) Stake Boosted by New York State Common Retirement Fund
New York State Common Retirement Fund boosted its stake in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) by 23.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,926,968 shares of the company's stock after
Enfusion, Inc. stock logo
Enfusion (NYSE:ENFN) Hits New 1-Year High - Here's What Happened
Enfusion (NYSE:ENFN) Sets New 1-Year High - Should You Buy?
Enfusion, Inc. stock logo
Enfusion, Inc. (NYSE:ENFN) Sees Significant Increase in Short Interest
Enfusion, Inc. (NYSE:ENFN - Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 1,010,000 shares, a growth of 41.9% from the January 15th total of 711,700 shares. Based on an average trading volume of 797,400 shares, the days-to-cover ratio is currently 1.3 days. Approximately 2.4% of the shares of the stock are sold short.
Enfusion, Inc. stock logo
Enfusion, Inc. (NYSE:ENFN) Given Average Rating of "Hold" by Brokerages
Shares of Enfusion, Inc. (NYSE:ENFN - Get Free Report) have been assigned an average recommendation of "Hold" from the six brokerages that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and t
Enfusion, Inc. stock logo
Enfusion, Inc. (NYSE:ENFN) Shares Sold by SG Americas Securities LLC
SG Americas Securities LLC trimmed its position in Enfusion, Inc. (NYSE:ENFN - Free Report) by 72.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,929 shares of the company's stock
Enfusion, Inc. stock logo
Enfusion, Inc. (NYSE:ENFN) Sees Large Growth in Short Interest
Enfusion, Inc. (NYSE:ENFN - Get Free Report) was the target of a large growth in short interest in January. As of January 15th, there was short interest totalling 711,700 shares, a growth of 27.9% from the December 31st total of 556,500 shares. Based on an average daily volume of 695,500 shares, the short-interest ratio is currently 1.0 days. Approximately 1.5% of the shares of the stock are short sold.
Enfusion, Inc. stock logo
Enfusion, Inc. (NYSE:ENFN) Shares Bought by JPMorgan Chase & Co.
JPMorgan Chase & Co. grew its stake in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) by 612.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 208,022 shares of the company's stock a
William Blair downgrades Enfusion (ENFN) to a Hold
Enfusion, Inc. stock logo
Enfusion (NYSE:ENFN) Sees Unusually-High Trading Volume - Here's Why
Enfusion (NYSE:ENFN) Sees Unusually-High Trading Volume - Should You Buy?
Enfusion, Inc. stock logo
Barclays PLC Boosts Stake in Enfusion, Inc. (NYSE:ENFN)
Barclays PLC lifted its position in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) by 251.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 86,039 shares of the company's stock after
Enfusion, Inc. stock logo
Enfusion, Inc. (NYSE:ENFN) Director Deirdre Somers Sells 1,637 Shares
Enfusion, Inc. (NYSE:ENFN - Get Free Report) Director Deirdre Somers sold 1,637 shares of the business's stock in a transaction on Monday, January 13th. The shares were sold at an average price of $10.53, for a total transaction of $17,237.61. Following the transaction, the director now owns 41,675 shares in the company, valued at $438,837.75. The trade was a 3.78 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Enfusion downgraded to Hold from Buy at Stifel
William Blair Downgrades Enfusion (ENFN)
Enfusion (ENFN) was downgraded to a Hold Rating at William Blair
Enfusion, Inc. stock logo
Enfusion's (ENFN) Market Perform Rating Reaffirmed at William Blair
William Blair reissued a "market perform" rating on shares of Enfusion in a research note on Monday.
Enfusion, Inc. stock logo
Enfusion (NYSE:ENFN) Shares Gap Up - What's Next?
Enfusion (NYSE:ENFN) Shares Gap Up - Here's Why
Clearwater Analytics Buys Enfusion in $1.5 Bln Deal
Clearwater To Acquire Enfusion - Quick Facts
Remove Ads
Get Enfusion News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter.

ENFN Media Mentions By Week

ENFN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ENFN
News Sentiment

1.63

0.80

Average
Computer and Technology
News Sentiment

ENFN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ENFN Articles
This Week

1

3

ENFN Articles
Average Week

Remove Ads
Get Enfusion News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:ENFN) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners